Last updated: 2026-09-07 05:41:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AngioDynamics, Inc. (ANGO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $15.19, with a market capitalization of $645.61M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.39 to $16.29. This page covers its latest market performance, valuation, price trends and company information.
$645.61M | |
$15.36 | |
$32.00 | |
$5.26 | |
$15.47 | |
430.23K | |
-- | |
-- | |
$16.29 | |
$9.39 | |
-- | |
-- |
AngioDynamics, Inc. (ANGO) last closed at $15.47 as of 2026-09-04 23:31:00, unchanged from the previous close of $15.47.
During the latest regular trading session, ANGO traded between $5.26 and $32.00, with a volume of 430.23K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, AngioDynamics, Inc. (ANGO) moved from $15.80 to $15.19, representing a decline of 3.85% ($0.61).
The stock traded between $14.83 and $15.44 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 338.54 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 84.1%
ANGO is currently trading at $15.19, placing it 84.1% of the way from its 52-week low of $9.39 to its 52-week high of $16.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 632 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AngioDynamics, Inc. (ANGO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.